Rebalix
Invesco · sheet of 10 September 2026
Invesco · sheet of 10 September 2026ETF sheet · official issuer and register data
Invesco GBP Corporate Bond Screened & Tilted UCITS ETF Dist
IGBE · IE00BKW9SV11 · class Dist · GBP · domicile Ireland
Bonds · Corporate GBP · Broad (all maturities) · EuropeSFDR art. 8
Index tracked: Bloomberg MSCI Sterling Liquid Corporate Screened & Tilted Index
- TER
- 0.10%+ trans. 0.12%
- Fund size
- 207 m EUR
- Tracking difference
- −0.14%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingquarterly
- Duration
- 5.06 yrsmedium (3–7 years)
Launch 25 Feb 2020 · costs from the KID as of 14 Aug 2026 · 495 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The investment objective of the Fund is to achieve the total return performance of the Bloomberg MSCI Sterling Liquid Corporate Screened & Tilted Index (the "Index"), less fees, expenses and transaction costs. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective, the Fund will employ sampling techniques to select securities in the Index which may include but are not limited to index weighted average duration, industry sectors, country weights, liquidity and credit quality. The use of the…
Performance since series start (in euro) — base 100
25 Feb 2020 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.7% |
| 3 years | +19.0% |
| 5 years | −3.5% |
| 10 years | series too young |
| Since series start | −2.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.17% | 5.19% | 7.00% |
| Max drawdown | −5.01% | −5.30% | −30.48% |
| Sharpe | -0.77 | -0.33 | -0.97 |
| Sortino | -0.98 | -0.43 | -1.29 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IGBE · IE00BKW9SV111
RebalixIGBE · IE00BKW9SV11 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +7.15% | +7.27% | −0.13% |
| 2024 | +2.53% | +2.64% | −0.11% |
| 2023 | +9.65% | +9.81% | −0.17% |
| 2022 | −18.58% | −18.36% | −0.21% |
| 2021 | −3.57% | −3.36% | −0.21% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.9%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in GBP
Frequency: quarterly · last 12 months: 2.0533 GBP (6.32% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 1.2502 | — |
| 2025 | 4 | 1.6055 | +4.92% |
| 2024 | 4 | 1.4985 | +4.50% |
| 2023 | 4 | 1.2849 | +4.07% |
| 2022 | 4 | 0.7848 | +1.98% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BKW9SV11
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BKW9SV11
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IGBE · IE00BKW9SV112